← All stocks

Gain Therapeutics, Inc.

GANX Net buying

CIK 0001819411 #4414 in the set updated 21 Sep 2026

Bought (120 mo)

$24.54M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$5.06K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$5.06K

2 of 2 sales

Net

+$24.54M

+$24.54M against sales at will

By person

6 insiders · 12 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Calabrese Salvatore

Chief Financial Officer

$24.30M (1)

—

+$24.30M

—

Riley Jeffrey Scott

Director

$115.77K (1)

—

+$115.77K

30,000

0.0687%

$29.96K

—

RICHMAN ERIC I

Director

$64.11K (5)

—

+$64.11K

289,629

0.6636%

$289.28K

+47.0%

Islam Khalid

Director

$49.94K (1)

—

+$49.94K

50,000

0.1146%

$49.94K

—

Mack Gene

CEO, President

$14.54K (1)

—

+$14.54K

14,400

0.0330%

$14.38K

—

Alder Matthias

Chief Executive Officer

—

$5.06K (2)

−$5.06K

21,140

0.0484%

$21.11K

+1,124%

Individual transactions

Insider

Date

Role

Action

Price

Amount

RICHMAN ERIC I

16 Aug 2021

Director

Exercised, kept

4,922

$7.87

$38.72K

Show all 12 transactions →

What was left out

Form 4 filings counted 64

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 93,431

History held since 17 Aug 2021